Psychopharmacology and Psychiatry Updates

En podcast av Psychopharmacology Institute

Kategorier:

252 Avsnitt

  1. Antipsychotics for First Episodes of Psychosis

    Publicerades: 2022-04-12
  2. Effects on Suicidal Risk With Different Medications

    Publicerades: 2022-04-07
  3. Risks of Using Cannabinoids

    Publicerades: 2022-04-02
  4. Lithium: How to Manage Dosage

    Publicerades: 2022-03-28
  5. CBD as a Medication

    Publicerades: 2022-03-23
  6. SSRIs and Suicidality

    Publicerades: 2022-03-18
  7. Cannabis and Cognition

    Publicerades: 2022-03-13
  8. Clozapine-Induced Myocarditis

    Publicerades: 2022-03-08
  9. Does Cannabis Use Cause Psychiatric Disorders?

    Publicerades: 2022-03-03
  10. Treatment Strategies for Treatment-Resistant OCD

    Publicerades: 2022-02-26
  11. Lithium Augmentation for Psychotic Depression

    Publicerades: 2022-02-21
  12. Prevention and Treatment Strategies for Agitation and Dementia

    Publicerades: 2022-02-16
  13. Choosing an Antipsychotic for Psychotic Depression

    Publicerades: 2022-02-11
  14. Neurological and Psychiatric Sequelae Due to COVID-19

    Publicerades: 2022-02-06
  15. SNRIs + Antipsychotics for Psychotic Depression

    Publicerades: 2022-02-01
  16. Approaches for Addressing Tobacco Use Disorder

    Publicerades: 2022-01-27
  17. ECT the First-Choice Treatment for Psychotic Depression

    Publicerades: 2022-01-22
  18. Metabolic Characteristics of Newer Second-Generation Antipsychotics

    Publicerades: 2022-01-17
  19. Prescribing Antipsychotics During Breastfeeding

    Publicerades: 2022-01-12
  20. Fluvoxamine for Treating COVID-19

    Publicerades: 2022-01-07

11 / 13

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

Visit the podcast's native language site